Session Details

How N-terminal pro-brain natriuretic peptide (NT-proBNP) can help us all along heart failure patient journey: from guidelines to implementation in our daily practice
27 Aug 12:45 - 13:45 Heart failure, other Satellite Symposium Dublin - Village 1
Chairpersons: Martin COWIE (London, United Kingdom), Antoni BAYES GENIS (Badalona, Spain)
Subtitle: Sponsored by Roche Diagnostics International
Learning Objectives: In recently published 2016 ESC HF Guidelines, NT-proBNP is recognized along heart failure patient journey, as the initial diagnostic test (Class I, LOE A ), in optimal pre-discharge planing for prognostic information and in out-patient setting for regular follow-up and monitoring to detect the development of complications or disease progression that may require a change in management. Experts will share the latest scientific knowledge as well as their experience from clinical practice with regard to the application and benefits of NT-proBNP along heart failure patient journey.

Abstract Access slides, videos, reports online via ESC Congress 365 Other resources

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
12:451809Introduction - How NT-proBNP can help us all along heart failure patient journey: from guidelines to implementation in our daily practice.Martin COWIE (London, United Kingdom), Antoni BAYES GENIS (Badalona, Spain)
12:471810The role and the place of natriuretic peptides in the 2016 ESC Guidelines.Alexandre MEBAZAA (Paris, France)
13:051811From guidelines to implementation in our daily practice: use of natriuretic peptides in clinical cases.Yigal PINTO (Amsterdam, Netherlands)
13:251812Panel discussion - How NT-proBNP can help us all along heart failure patient journey: from guidelines to implementation in our daily practice.